Next Article in Journal
Effect of High-Pressure Homogenization on the Formulation of Micro- and Nanocrystals Containing Poorly Watersoluble Meloxicam
Previous Article in Journal
A Rapid, Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Formoterol Fumarate, Tiotropium Bromide, and Ciclesonide in a Pulmonary Drug Product
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Sci. Pharm.
Volume 80
Issue 3
10.3797/scipharm.1204-13
scipharm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Identification and Characterization of Potential Impurities in Raloxifene Hydrochloride

by
Reguri BUCHI REDDY
1,*,
Thirumani VENKATESHWAR GOUD
1,
Nagabushanam NAGAMANI
1,
Nutakki PAVAN KUMAR
1,
Anandan ALAGUDURAI
1,
Raman MURUGAN
2,
Kannabiran PARTHASARATHY
2,
Vinayagam KARTHIKEYAN
2 and
Perumal BALAJI
2
1
Chemical Research & Development, NPNC Division, Orchid Chemicals and Pharmaceutical Limited, Sozhanganallur, Chennai 600 119, Tamilnadu, India
2
Analytical Research & Development, Orchid Chemicals and Pharmaceutical Limited, Sozhanganallur, Chennai 600 119, Tamilnadu, India
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2012, 80(3), 605-618; https://doi.org/10.3797/scipharm.1204-13
Submission received: 16 April 2012 / Accepted: 22 May 2012 / Published: 22 May 2012
Versions Notes

Abstract

During the synthesis of the bulk drug Raloxifene hydrochloride, eight impurities were observed, four of which were found to be new. All of the impurities were detected using the gradient high performance liquid chromatographic (HPLC) method, whose area percentages ranged from 0.05 to 0.1%. LCMS was performed to identify the mass number of these impurities, and a systematic study was carried out to characterize them. These impurities were synthesized and characterized by spectral data, subjected to co-injection in HPLC, and were found to be matching with the impurities present in the sample. Based on their spectral data (IR, NMR, and Mass), these impurities were characterized as Raloxifene-N-Oxide [Impurity: 1]; EP impurity A [Impurity: 2]; EP impurity B [Impurity: 3]; Raloxifene Dimer [Impurity: 4]; HABT (6-Acetoxy-2-[4-hydroxy-phenyl]-1-benzothiophene or 6-Hydroxy-2-[4-acetoxyphenyl]-1-benzothiophene) [Impurity: 5]; PEBE (Methyl[4-[2-(piperidin-1-yl)ethoxy]]benzoate) [Impurity: 6]; HHBA (1-[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]ethanone) [Im-purity: 7]; 7-MARLF (7-Acetyl-[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl][4-[2-(piperidin-1-yl)ethoxy]phenyl methanone) [Impurity: 8]; of which impurities 5–8 are reported for the first time.
Keywords: Raloxifene; Impurities; Isolation; Synthesis; Preparative high performance liquid chromatography; Characterization; Evista Raloxifene; Impurities; Isolation; Synthesis; Preparative high performance liquid chromatography; Characterization; Evista

Share and Cite

MDPI and ACS Style

BUCHI REDDY, R.; VENKATESHWAR GOUD, T.; NAGAMANI, N.; PAVAN KUMAR, N.; ALAGUDURAI, A.; MURUGAN, R.; PARTHASARATHY, K.; KARTHIKEYAN, V.; BALAJI, P. Identification and Characterization of Potential Impurities in Raloxifene Hydrochloride. Sci. Pharm. 2012, 80, 605-618. https://doi.org/10.3797/scipharm.1204-13

AMA Style

BUCHI REDDY R, VENKATESHWAR GOUD T, NAGAMANI N, PAVAN KUMAR N, ALAGUDURAI A, MURUGAN R, PARTHASARATHY K, KARTHIKEYAN V, BALAJI P. Identification and Characterization of Potential Impurities in Raloxifene Hydrochloride. Scientia Pharmaceutica. 2012; 80(3):605-618. https://doi.org/10.3797/scipharm.1204-13

Chicago/Turabian Style

BUCHI REDDY, Reguri, Thirumani VENKATESHWAR GOUD, Nagabushanam NAGAMANI, Nutakki PAVAN KUMAR, Anandan ALAGUDURAI, Raman MURUGAN, Kannabiran PARTHASARATHY, Vinayagam KARTHIKEYAN, and Perumal BALAJI. 2012. "Identification and Characterization of Potential Impurities in Raloxifene Hydrochloride" Scientia Pharmaceutica 80, no. 3: 605-618. https://doi.org/10.3797/scipharm.1204-13

APA Style

BUCHI REDDY, R., VENKATESHWAR GOUD, T., NAGAMANI, N., PAVAN KUMAR, N., ALAGUDURAI, A., MURUGAN, R., PARTHASARATHY, K., KARTHIKEYAN, V., & BALAJI, P. (2012). Identification and Characterization of Potential Impurities in Raloxifene Hydrochloride. Scientia Pharmaceutica, 80(3), 605-618. https://doi.org/10.3797/scipharm.1204-13

Article Metrics

Back to TopTop